Nuvalent, Inc.
Key Metrics
Market Snapshot
About
Nuvalent, Inc. is a precision oncology company developing targeted therapies for patients with ROS1-positive and ALK-positive non-small cell lung cancer and other cancers driven by these kinase targets.